Transgenic animals with serious disorders related to Alzheimer's disease

Details for Australian Patent Application No. 2004277357 (hide)

Owner Aventis Pharma S.A.

Inventors Pradier, Laurent; Itier, Jean-Michel; Blanchard-Bregeon, Veronique; Casas Louzao, Caty; Tremp, Gunter; Benoit, Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2004277357

PCT Pub. Number WO2005/032244

Priority 0311578 02.10.03 FR

Filing date 27 September 2004

Wipo publication date 14 April 2005

Acceptance publication date 3 November 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032244 Priority application(s): WO2005/032244

3 November 2011 Application Accepted

  Published as AU-B-2004277357

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277358-Method for avoiding clogging of filtration membranes

2004277356-Intervertebral implant